Vetter’s Clinical Facility Demonstrates Success with Five Client Products Now on the Market


Both the US Skokie and European Rankweil sites address customer needs in early-phase drug development

  • Clinical development pipeline is essential to global business strategy
  • for in-human trial materialVetter Development Service offers comprehensive expertise
  • New facility in Austria expands clinical manufacturing capacity

RAVENSBURG, GERMANY AND RANKWEIL, AUSTRIA, AND SKOKIE, US – , the company has long-term experience in supporting biotechnology and pharmaceutical customers both large and small. Vetter range from early stage development support including , to and for vials, syringes and cartridges. As a leading solution provider, Vetter appreciates its responsibility to support the needs of its customers by developing devices that contribute to increased patient safety, convenience, and enhanced compliance. Great importance is also given to including environmental protection and sustainability. Learn more about Vetter at